Found: 11
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 549, doi. 10.1002/cpdd.978
- Publication type:
- Article
A Phase 1 First‐in‐Human Single‐Ascending‐Dose Trial With ESB1609, a Selective Agonist to the Sphingosine‐1‐Phosphate Receptor 5.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 625, doi. 10.1002/cpdd.1256
- By:
- Publication type:
- Article
Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 553, doi. 10.1002/cpdd.1255
- By:
- Publication type:
- Article
A Phase 1 First‐in‐Human Pharmacokinetic and Pharmacodynamic Study of JNJ‐64264681, a Covalent Inhibitor of Bruton's Tyrosine Kinase.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 611, doi. 10.1002/cpdd.1253
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of Fluconazole Capsules Manufactured in France and China in Healthy Chinese Participants: Open‐Label, Randomized, Single‐Dose, 2‐Way, Crossover Bioequivalence Study Under Fasted and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 572, doi. 10.1002/cpdd.1248
- By:
- Publication type:
- Article
Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase 1, Open‐Label Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 645, doi. 10.1002/cpdd.1247
- By:
- Publication type:
- Article
Effect of Dietary Intake on the Pharmacokinetics of the Multitargeted Receptor Tyrosine Kinase Inhibitor Famitinib: Results From a Phase 1 Study in Healthy Chinese Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 639, doi. 10.1002/cpdd.1238
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Single and Multiple Daily Dosing of 75‐mg Rimegepant Orally Disintegrating Tablets in Healthy Chinese Adults: A Randomized Placebo‐Controlled Trial.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 594, doi. 10.1002/cpdd.1230
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Bioequivalence of 2 Lopinavir/Ritonavir (200/50 mg) Tablets in Healthy Chinese Volunteers: Effect of Food on Absorption.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 602, doi. 10.1002/cpdd.1229
- By:
- Publication type:
- Article
Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 579, doi. 10.1002/cpdd.1216
- By:
- Publication type:
- Article
Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Formulations of 0.2‐g Ibuprofen Granules.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 588, doi. 10.1002/cpdd.1211
- By:
- Publication type:
- Article